In contrast, Harry et al. [44] have reported that Saccharomyces and especially Saccharomyces cerevisiae show a markedly decreased abundance in patients with IBD, whereas S. cerevisiae exhibits anti-inflammatory effects involving increased secretion of IL-10. Here, IL10 is linked to inflammatory bowel disease.